![Toby Ferguson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Toby Ferguson
Corporate Officer/Principal bij
Temple University School of Medicine
Vermogen: 759 199 $ op 30-06-2026
Profiel
Toby Ferguson is currently an Assistant Professor-Neurology at Temple University School of Medicine.
Formerly, Dr. Ferguson was Chief Medical Officer at Voyager Therapeutics, Inc. from 2024 to 2026 and VP & Head-Neuromuscular Development Unit at Biogen, Inc. from 2020 to 2024.
Education includes a doctorate from the University of Florida College of Medicine and an undergraduate degree from the University of Florida.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 216.914 ( 0,36% ) | 759 199 $ | 30-06-2026 |
Actieve functies van Toby Ferguson
| Bedrijven | Functie | Begin |
|---|---|---|
Temple University School of Medicine
 Temple University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Eerdere bekende functies van Toby Ferguson
| Bedrijven | Functie | Einde |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 20-02-2026 |
| BIOGEN INC. | Hoofd Techniek/Wetenschap/O&O | 01-07-2019 |
Opleiding van Toby Ferguson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
78
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Temple University School of Medicine
Temple University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Florida College of Medicine
 University of Florida College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies MarketScreener 
